Renal Mass Registry

Sponsor

Mayo Clinic (Other)

Overall Status

Completed

CT.gov ID

NCT01887574

Collaborator

(none)

141

Enrollment

Location

Arm

46.4

Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Collect valuable risk factor and quality of life data from Renal Cell Carcinoma patients and harness the latest technology to organize and analyze data.

Condition or Disease	Intervention/Treatment	Phase
Renal Cell Carcinoma	Other: questionnaire	N/A

Detailed Description

RCC is a cancer that is poorly understood. The increase in both incidence and mortality rates for RCC, coupled with the lack of effective therapies for RCC beyond surgical excision, underscore the need for a better understanding of RCC tumor biology, immunology, and epidemiology. Such improved understanding could then be directly translated into new prevention strategies as well as improved patient care. Recently, the National Cancer Institute's Kidney Cancer Progress Review Group identified as top priorities for future research the need to better understand the mechanisms underlying known risk factors for kidney cancer; and examine tumor tissue to identify predictors of patient outcome and targets for therapy. In addition, the review group stressed that the leaders in renal cancer research over the next decade would be those institutions that could enroll large numbers of patients, collect valuable risk factor and quality of life data from these patients and harness the latest technology to organize and analyze data.

Study Design

Study Type:

Interventional

Actual Enrollment :

141 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Other

Official Title:

Renal Mass Registry

Study Start Date :

Jun 1, 2013

Actual Primary Completion Date :

Apr 12, 2017

Actual Study Completion Date :

Apr 12, 2017

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Open	Other: questionnaire questionnaires given to all patients to assess risk factors and quality of life

Arm

Intervention/Treatment

Experimental: Open

Other: questionnaire

questionnaires given to all patients to assess risk factors and quality of life

Outcome Measures

Primary Outcome Measures

Evidence of Renal Mass Risk Factors as determined by patient questionnaire post surgery [5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion:

Patients with a renal mass or a suspected metastatic lesion from a renal primary who have been treated or are going to be studied and or treated surgically at Mayo Clinic Arizona
Patients must be 18 years of age or older
Patients must be capable of and willing to sign an informed consent

Exclusion:

None

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Mayo Clinic in Arizona	Scottsdale	Arizona	United States	85259

Sponsors and Collaborators

Mayo Clinic

Investigators

Principal Investigator: Erik Castle, MD, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Mayo Clinic Clinical Trials

Publications

None provided.

Responsible Party:

Mayo Clinic

ClinicalTrials.gov Identifier:

NCT01887574

Other Study ID Numbers:

13-002688

First Posted:

Jun 27, 2013

Last Update Posted:

Jun 17, 2020

Last Verified:

Jun 1, 2020

Additional relevant MeSH terms:

Carcinoma, Renal Cell

Study Results

No Results Posted as of Jun 17, 2020